Condition (MeSH)
Lip Neoplasms
ClinicalTrials.gov lists 20 trials for Lip Neoplasms or a narrower condition beneath it. Alpha Tau Medical LTD. has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Lip Neoplasms itself; the rest are tagged with a narrower condition beneath it.
When did Lip Neoplasms trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 3 |
| 2018 | 3 |
| 2017 | 3 |
| 2013 | 1 |
| 2007 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Lip Neoplasms trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Not applicable | 6 |
| Observational | 9 |
How many Lip Neoplasms trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Completed | 8 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Lip Neoplasms trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alpha Tau Medical LTD. | 6 |
| Klus Pharma Inc. | 1 |
| Travera Inc | 1 |
| Vical | 1 |
| Vigilant Biosciences, Inc. | 1 |
Which drugs are being tested for Lip Neoplasms? (7)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| DURVALUMAB | 1 |
| A166 | 1 |
| Ficlatuzumab | 1 |
| PEMBROLIZUMAB | 1 |
| Ficerafusp alfa | 1 |
Showing 5 of 7 drugs.
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| or carboplatin | 1 |
| Cisplatin 1 | 1 |
| Allovectin-7® | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Lip Neoplasms trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Lung infection | 6 | 2 |
| Dysphagia | 5 | 2 |
| Bacteremia | 3 | 1 |
| Dehydration | 3 | 2 |
| Thromboembolic event | 3 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Lip Neoplasms? (19)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Incidence Trends of Lip, Oral Cavity, and Pharyngeal Cancers: Global Burden of Disease 1990-2017. | Journal of dental research | 2020 | Yes |
| Squamous Cell Carcinoma of the Lip-A Review of Squamous Cell Carcinogenesis of the Mucosal and Cutaneous Junction. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] | 2017 | Yes |
| Lip Cancer: A Clinicopathological Study and Treatment Outcomes in a 25-Year Experience. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons | 2016 | Yes |
| Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas. | Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology | 2016 | Yes |
| Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis. | JAMA otolaryngology-- head & neck surgery | 2016 | Yes |
Showing 5 of 19 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.